Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody

J Neurol. 2009 Feb;256(2):287-8. doi: 10.1007/s00415-009-0139-4. Epub 2009 Mar 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aquaporin 4 / immunology*
  • Autoantibodies / analysis
  • Autoantibodies / blood*
  • Biomarkers / analysis
  • Biomarkers / blood
  • Disease Progression
  • Female
  • Humans
  • Hypothalamus / pathology
  • Hypothalamus / physiopathology
  • Immunosuppressive Agents / therapeutic use
  • Intracellular Signaling Peptides and Proteins / analysis
  • Intracellular Signaling Peptides and Proteins / cerebrospinal fluid
  • Magnetic Resonance Imaging
  • Mesencephalon / pathology
  • Mesencephalon / physiopathology
  • Methylprednisolone / therapeutic use
  • Narcolepsy / immunology*
  • Narcolepsy / pathology
  • Narcolepsy / physiopathology*
  • Neuromyelitis Optica / complications*
  • Neuromyelitis Optica / immunology*
  • Neuromyelitis Optica / pathology
  • Neuropeptides / analysis
  • Neuropeptides / cerebrospinal fluid
  • Ocular Motility Disorders / etiology
  • Ocular Motility Disorders / pathology
  • Ocular Motility Disorders / physiopathology
  • Orexins
  • Polysomnography
  • Predictive Value of Tests
  • Recurrence
  • Spinal Cord / pathology
  • Spinal Cord / physiopathology
  • Treatment Outcome

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Autoantibodies
  • Biomarkers
  • Immunosuppressive Agents
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Methylprednisolone